Search   
MSDS  : 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R-(2-alpha,3Z,5-alpha))-
CAS  : 61177-45-5
SYNONYMS  : * BRL 14151K * Potassium clavulanate
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : RN6802700
CHEMICAL NAME : 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,
3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt,
(2R-(2-alpha,3Z,5-alpha))-
CAS REGISTRY NUMBER : 61177-45-5
LAST UPDATED : 199510
DATA ITEMS CITED : 17
MOLECULAR FORMULA : C8-H8-N-O5.K
MOLECULAR WEIGHT : 237.27
COMPOUND DESCRIPTOR : Reproductive Effector
SYNONYMS/TRADE NAMES :
* BRL 14151K
* Potassium clavulanate

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 7936 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1399 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1398 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 326 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),69,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1680 mg/kg
TOXIC EFFECTS :
Skin and Appendages - hair
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),69,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4526 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1531 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2185 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 348 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),69,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Skin and Appendages - dermatitis, other (after systemic exposure)
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),69,1986

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 45 gm/kg/30D-C
TOXIC EFFECTS :
Endocrine - changes in thymus weight
Blood - normocytic anemia
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),113,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 72800 mg/kg/26W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Kidney, Ureter, Bladder - urine volume decreased
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),180,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 2800 mg/kg/5W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Blood - normocytic anemia
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - phosphatases
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),96,1986

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 500 mg/kg
SEX/DURATION : female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Effects on Newborn - sex ratio
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),238,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 100 mg/kg
SEX/DURATION : female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),238,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 11200 mg/kg
SEX/DURATION : female 15-21 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
31(Suppl 2),252,1983

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE : 1650 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
34(Suppl 4),69,1986

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,3-ethyl-4-methylene-8-(2-phenylethyl)- 134069-67-3
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(3-(p-fluorobenzoyl)propyl)-3,4-dimethyl-,hydrochloride 102504-25-6
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(p-fluorophenethyl)- 5500-76-5
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-3,4-dimethyl- 134070-06-7
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-4-methyl-3-(phenylmethyl)-, monohydrochloride 134070-05-6
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-4-methyl-3-(1-methylethyl)- 134070-11-4
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-4-methyl-3-propyl-, monohydrochloride 134070-14-7
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-,(2R-(2-alpha,3Z,5-alpha))- 58001-44-8
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-4-methyl-3-(1-naphthalenyl)-, monohydrochloride 134070-18-1
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-hydroxy-4-methyl-3-phenyl-, monohydrochloride 134070-23-8
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-methylene-3-(phenylmethyl)- 134069-53-7
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-methylene-3-(1-methylethyl)- 134069-74-2
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-methylene-3-(1-naphthalenyl)- 134069-88-8
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-methylene-3-phenyl- 134069-66-2
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-4-methylene-3-propyl- 134069-76-4
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-fluorophenyl)ethyl)-3-methyl-4-methylene- 134069-72-0
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(3-(2-furyl)propyl)-, hydrochloride 23805-00-7
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,4-hydroxy-3,4-dimethyl-8-(2-phenylethyl)- 134070-04-5
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-, (2R-(2-alpha,3Z,5-alpha))-, mixt. with(2S-(2-alpha,5-alpha,6-beta(S*)))-6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane- 2-carboxylic acid 86482-18-0
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(4-hydroxy-3-(methoxycarbonyl))benzyl-, succinate 74195-67-8
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-hydroxy-3-phenyl)propyl- 5229-85-6
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(beta-methoxyphenethyl)-, hydrochloride 23804-90-2
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(p-methoxyphenethyl)-, hydrochloride 23804-74-2
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(o-methoxyphenoxy)ethyl)-, hydrochloride 23804-93-5
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(3,4-(methylenedioxy)phenethyl)- 5229-89-0
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,4-methylene-8-(2-phenylethyl)-3-propyl- 134069-98-0
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,4-methylene-3-phenyl-8-(2-phenylethyl)- 134069-60-6
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,3-methyl-4-methylene-8-(2-phenylethyl)- 134069-62-8
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-((alpha-methyl)phenethyl)- 5053-09-8
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt,(2R-(2-alpha,3Z,5-alpha))- 61177-45-5
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(p-methylphenethyl)-, hydrochloride 23804-73-1
1-Oxa-3,8-diazaspiro(4.5)decan-2-one, 8-(phenacyl)-,hydrochloride 23804-95-7
1-Oxa-3,8-diazaspiro(4.5)decan-2-one, 8-phenethyl- 5053-06-5
1-Oxa-3,8-diazaspiro(4.5)decan-2-one, 8-phenethyl-,monohydrochloride 5053-08-7
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-phenoxyethyl)-, hydrochloride 5052-99-3
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(3-phenylpropenyl)- 23804-85-5
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(3-phenyl)propyl-, hydrochloride 6110-67-4
1-Oxa-3,8-diazaspiro(4.5)decan-9-one,8-(p-propionamido)phenethyl-, hydrochloride 69382-12-3
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(2-pyridyl)ethyl)- 23804-98-0
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(2-(4-pyridyl)ethyl)-, dihydrochloride 23804-99-1
Osbeckia aspera (L.) Bl. var. travancorica (bedd. exGamble) Hanson, extract excluding rootsSUBSTANCE DEFINITION :Plant belonging to the family MelastomataceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-Volume(issue)/page/year: 22,487,1984 23804-99-1
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt,(2R-(2-alpha,3Z,5-alpha))-, mixt. with(2S-(2-alpha,5-alpha,6-beta(S*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4- thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (1:2) 74469-00-4
1-Oxa-3,8-diazaspiro(4.5)decan-2-one,8-(m-(trifluoromethyl)phenethyl)-, hydrochloride 23804-75-3
9-Oxa-2,4-diazaspiro(5.5)undecane-1,3,5-trione,8,10-bis(bromomethyl)- 99359-52-1
9-Oxa-2,4-diazaspiro(5.5)undecane-1,3,5-trione,8,10-bis(iodomethyl)- 56865-28-2
9-Oxa-2,4-diazaspiro(5.5)undecane-1,3,5-trione,8-(bromomethyl)-10-methyl- 56865-27-1
9-Oxa-2,4-diazaspiro(5.5)undecane-1,3,5-trione,8-(iodomethyl)-10-methyl- 99074-75-6
1-Oxa-3,9-diazaspiro(5.5)undecan-2-one,9-(3-(p-chlorobenzoyl)propyl)- 54981-19-0
1-Oxa-3,9-diazaspiro(5.5)undecan-2-one,9-(3-(p-chlorobenzoyl)propyl)-5-methyl- 54981-20-3
1-Oxa-3,9-diazaspiro(5.5)undecan-2-one,5-ethyl-9-(3-(p-chlorobenzoyl)propyl)- 54981-21-4

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net